The peptides under review at the July 2026 FDA meeting including BPC-157, TB-500, CJC-1295, and others are not FDA-approved drugs and will not become FDA-approved drugs as a result of this meeting
Variants in FTO (the fat-mass and obesity-associated gene), MC4R (a melanocortin receptor central to satiety and energy balance), GLP1R (the receptor every GLP-1 compound targets), and TCF7L2 (a transcription factor linked to glucose homeostasis) describe the baseline terrain a GLP-1 protocol acts on
Given that, today our Registered Dietitian is breaking down whether or not you should count calories on a GLP-1
And with that, lets go ahead and circle back to our claim, which is men can develop erectile dysfunction from GLP-1 agonists
After plateauing on those two drugs, Schram is trying a new experimental drug thats being hailed as better than Ozempic